BioNTech SE (BNTX)
102.92
+0.80
(+0.78%)
USD |
NASDAQ |
Apr 17, 16:00
101.68
-1.24
(-1.20%)
Pre-Market: 08:30
BioNTech SG&A Expense (Quarterly) : 253.62M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| AstraZeneca PLC | 152.78M |
| GSK Plc | 3.510B |
| Merck & Co., Inc. | 2.898B |
| Novavax, Inc. | 34.12M |
| Moderna, Inc. | 308.00M |